Why IL-12 Receptor Antagonists Are Emerging as a Strategic Focus in Precision Immunology
IL-12 receptor antagonists are gaining attention as precision immunology moves from broad suppression to targeted pathway control. By interrupting IL-12 signaling, these therapies may help reduce the inflammatory cascade that drives autoimmune and chronic immune-mediated diseases. For biotech leaders and healthcare strategists, the relevance is clear: the market is shifting toward treatments that aim to …
Why IL-12 Receptor Antagonists Are Emerging as a Strategic Focus in Precision Immunology Read More »